United Health Products (UEEC) Non-Current Deffered Revenue (2022 - 2023)
United Health Products (UEEC) reported Non-Current Deffered Revenue of $132281.0 for Q2 2023, down 29.51% quarter-over-quarter from $187668.0 in Q1 2023.
United Health Products (UEEC) Non-Current Deffered Revenue (2022 - 2023) Analysis & Trends
United Health Products (UEEC) has 2 years of Non-Current Deffered Revenue data on file, last reported at $132281.0 in Q2 2023.
- Non-Current Deffered Revenue for Q2 2023 came in at $132281.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $132281.0 (changed N/A YoY), and the FY2022 annual result was $243039.0, changed N/A from the prior year.
- Non-Current Deffered Revenue fell to $132281.0 in Q2 2023 per UEEC's latest filing, from $187668.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $250000.0 in Q3 2022 and troughed at $132281.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 163.15 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 11.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | United Health Products | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 132,281.00 |
| Mar 31, 2023 | 187,668.00 |
| Dec 31, 2022 | 243,039.00 |
| Sep 30, 2022 | 250,000.00 |